October 2010 Issue
Sputnik and Telecom have transformed analytics forever
The cost of sticking to the current pharma supply chain model is high, from a strategic and financial perspective. Here are five key areas where increased flexibility leads to competitive advantage.
Automotive, and pharma, innovation are far from dead, but will we see the type of innovation that survival demands?
Manufacturers look outside their walls for flow chemistry expertise.
It may be hard to find good help, but its also hard to find good work.
Are you not receiving important emails? Here are some whitelisting tips for you.
R&D must harness its inherent scientific horsepower and apply it through statistically unbiased experimental designs.
Since operators are fallible and low-throughput, manufacturers must automate inspection of visible particulates.
A discussion with Bill Ciambrone, Senior Vice President of Technical Operations for Shire Human Genetic Therapies, about critical issues in workforce training today.
Consultant Steve Sawin answers our questions about managing contingent labor.
As drug manufacturers struggle to train their workers, solution providers step in to help.
As FDA probes the connection between workforce training and quality, manufacturers must do the same.
Is it the employee that needs fixing, or the SOP?